Akin Gump Strauss Hauer & Feld LLP’s life sciences intellectual property practice focuses on litigation, post-grant proceedings and counseling on patent issues in the biological, chemical and medical device areas. Our team members are not only experienced litigators; they are patent lawyers, with every member admitted to practice before the U.S. Patent and Trademark Office. In addition, we are trained scientists, with the majority of our team members holding advanced degrees in the chemical or biochemical sciences. This combination of experience and training prepares our teams to successfully advise and represent clients in all aspects of complex life sciences patent disputes.
Members of our life sciences team have over 30 years of experience trying patent infringement cases in the life sciences arena and have been recognized by Chambers USA, Best Lawyers in America and IAM 2010 Life Sciences 250 as among the top life sciences patent litigators in the United States. In July 2009, partners Dianne Elderkin, Barbara Mullin and Steve Maslowski, along with a team of associates, obtained a jury verdict for their client of $1.67 billion, reported by Bloomberg to be the largest jury verdict at the time in U.S. history in a patent case. At the conclusion of the jury trial, the trial judge commented, referring to both parties’ teams of trial counsel, “You will never see a better group of lawyers.…” Although the judgment was later overturned on appeal when the Federal Circuit determined that the patent did not meet the written description requirement, Ms. Elderkin was named by The National Law Journal as “Litigator of the Week” for her work on the case. She is the first woman selected for this honor.